Guideline | Drug Name |
---|---|
Denosumab 60mg Products | Prolia (denosumab), Jubbonti (denosumab-bbdz), Stoboclo (denosumab-bmwo) |
Diabetic Agents | Cycloset (bromocriptine), Riomet (metformin) |
Diabetic GLP-1's | Bydureon BCise (exenatide extended-release), Byetta (exenatide injection), Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (semaglutide), Trulicity (dulaglutide), Victoza (liraglutide injection) |
Diacomit (stiripentol) | Diacomit (stiripentol) |
Dibenzyline (phenoxybenzamine) | Dibenzyline (phenoxybenzamine) |
Dichlorphenamide Agents | Keveyis (dichlorphenamide), Ormalvi (dichlorphenamide) |
Dojolvi (triheptanoin) | Dojolvi (triheptanoin) |
Doptelet (avatrombopag) | Doptelet (avatrombopag) |
DPP-4 Inhibitors - ST, NF | Kazano (alogliptin/metformin), Kombiglyze XR (saxagliptin/metformin), Nesina (alogliptin), Onglyza (saxagliptin), Oseni (alogliptin/pioglitazone), Zituvimet (sitagliptin/metformin), Zituvimet XR (sitagliptin/metformin), Zituvio (sitagliptin) |
Duexis (ibuprofen and famotidine) | Duexis (ibuprofen/famotidine) |
Duobrii (halobetasol propionate and tazarotene) - PA, NF | Duobrii (halobetasol propionate and tazarotene) |
Dupixent (dupilumab) | Dupixent (dupilumab) |
Duvyzat (givinostat) | Duvyzat (givinostat) |
Dysport (abobotulinumtoxinA) | Dysport (abobotulinumtoxinA) |
Ebglyss (lebrikizumab-lbkz) | Ebglyss (lebrikizumab-lbkz) |
Eculizumab Products | Bkemv (eculizumab-aeeb), Epysqli (eculizumab-aagh), Soliris (eculizumab) |
Egrifta (tesamorelin) | Egrifta SV (tesamorelin) |
Elaprase (idursulfase) | Elaprase (idursulfase) [1] |
Elevidys (delandistrogene moxeparvovec-rokl) - PA, NF | Elevidys (delandistrogene moxeparvovec-rokl) |
Elmiron (pentosan polysulfate sodium) | Elmiron (pentosan polysulfate sodium) |